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Abstract 
Application of artificial pancreas systems represents a change in approach 
to managing complex glucose and insulin dynamics using automated 
features with higher levels of safety, precision and reliability than those 
afforded by manual adjustments. To date limited commercial systems and 
more widely used open-source, hybrid closed loop, Do-It-Yourself Artificial 
Pancreas Systems (DIY APS) have been used in non-trial real-world 
management of type 1 diabetes (T1D). The aims of this article are two-fold. 
Firstly, it aims to synthesize the emerging literature on DIY APS. It identifies 
a range of evidence including research, reviews, commentaries, and 
opinion pieces written by DIY APS users, healthcare professionals (HCP) 
and researchers. It seeks to summarize the emerging clinical evidence for 
DIY APS and provide insight into how the DIY APS movement began, has 
been disseminated throughout diabetes online communities and is re-
shaping self-management of T1D in real-world settings. Secondly, the 
article provides commentaries that explore implications of DIY APS to 
healthcare practice. DIY APS is radically changing T1D management. 
Automating the process of frequently analyzing glucose readings and 
appropriately titrating insulin delivery is liberating PWD from some of the 
demands of intensively managing T1D. Within this super-specialized area 
of T1D management, the expertise of DIY APS users has outstripped that 
of many HCP. While educational, ethical and legal constraints need to be 
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resolved, HCP still need to stay abreast of this rapidly developing area.  
Further research is needed to inform policy and practice relating to DIY 
APS. Meanwhile, HCP continue to learn from PWD’s real-world experiences 
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Introduction 
Improved glycemic control delays the progression towards complications in 
type 1 diabetes (T1D) [1]. Current outcomes highlight that only a minority of 
people with T1D (PWD) achieve recommended target goals for HbA1c in 
the US and UK [2,3]. Furthermore, the frequency of hypoglycemia has not 
decreased [4]. Despite recent developments in T1D management with 
newer insulins and technology, barriers in self-management severely limit 
the utility and adherence to these newer treatments. Such barriers include 
fear of hypoglycemia, diabetes related distress, psychological factors and 
intensive treatment regimens [5]. Hence, there is a strong need for further 
improvements in T1D care that can overcome these barriers.  
 
The concept of automation where glucose sensor readings independently 
guide smartphone applications to deliver or suspend insulin delivery via 
insulin pumps with minimal human intervention offers the potential to 
overcome human barriers whilst improving diabetes-related care. Recent 
advances in technologies have allowed wireless connectivity of continuous 
glucose monitoring (CGM) and continuous subcutaneous insulin infusion 
systems (CSII) with controllers that can alter insulin delivery in response to 
changes in interstitial glucose. Following the early development of low and 
predictive low glucose basal insulin suspension sensor augmented insulin 
pump systems, more recent algorithms for subcutaneous insulin dosing 
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have been developed that allow insulin dosing in an automated fashion via 
insulin pumps in response to changes in glucose detected by sensors [6–
9].  
 
In this review, we detail the emerging evidence for DIY APS. Whilst these 
systems are currently unregulated and not medically approved, their real-
world use highlights potential metabolic and psychological benefits. We 
discuss the recent ethical and legal constraints which need to be remedied 
if more PWD are to access and safely utilize DIY APS. Using these 
evidence-based insights, as well as experiential learning from our evolving 
clinical practice, we provide a commentary that details implications of DIY 
APS for healthcare professionals and healthcare practice. 
 
Background 
Frustrated by the slow pace of development of artificial pancreas systems, 
a community of PWD and their families/caregivers united online using the 
hashtag ‘#WeAreNotWaiting’ to promote the development of open source 
diabetes management systems. This DIY APS movement began via social 
media in 2013. Initially, it only included a few people who developed and 
shared computer codes from different programs to manage their CGM and 
insulin pumps [9]. Working together throughout the following year, they 
created and released the first open source artificial pancreas system 
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(OpenAPS). Throughout the last five years, the DIY movement has 
expanded exponentially.   
 
DIY APS use open-source software to automate insulin delivery (e.g. 
OpenAPS [10], AndroidAPS [11] or Loop [12]). Each of these systems uses 
algorithms to continually collect and analyze data on glucose, insulin and 
food to predict future glucose levels. Commands are issued via a to the 
insulin pump to adjust insulin delivery with reference to the programmed 
glucose target levels and other personalized settings. This information is 
continuously fed-back into the system where it is analyzed to make future 
adjustments [13].   
 
Some of the DIY APS set-ups require a hardware radio “bridge” (i.e. 
RileyLink) to communicate between the pump and the algorithm controller, 
due to the built-in radio communication of these particular pumps (older 
versions of Medtronic and OmniPod Eros pods). The software application 
AndroidAPS, which uses the OpenAPS algorithm in an Android app can 
communicate with numerous commercially available Bluetooth enabled 
insulin pumps (e.g. Sooil Dana R/RS, Roche Spirit Combo or Insight) and 
also Medtronic 512 – 554 pumps with a RileyLink.  All DIY APS use existing 
Continuous Glucose Monitoring (CGM) Systems, and some DIY APS users 
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choose to modify flash glucose monitors (e.g. Freestyle Libre with MiaoMiao 
adapter) as well [8]. 
 
People skilled in computing and self-managing diabetes continue to 
collaborate via social media platforms such as Twitter, Facebook and 
GitHub to further develop and improve technologies that help to automate 
the management of T1D. Current estimates suggest that there are 
approximately 1500 people worldwide using some form of DIY APS [14].  
 
Evidence Base for DIY APS 
A literature search was conducted via PubMed using the following terms: 
#WeAreNotWaiting, AndroidAPS, artificial pancreas system, automated 
insulin delivery; Do-It-Yourself, DIY, looping, nightscout, OpenAPS, open 
source and type 1 diabetes. 
 
23 publications relating to DIY APS or related aspects (i.e. Nightscout) were 
identified. These included five quantitative research studies (See Table 1.); 
two qualitative research studies (See Table 2.); 6 conference abstracts (See 
Table 3.) and 10 miscellaneous publications (e.g. a review article, a 
monograph, a case report, commentaries and editorials) (See Table 4.). 
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While few randomized control trials have been conducted on DIY APS, an 
OpenAPS data repository has been established [14]. This provides insight 
into the real-world use of DIY systems and also sets the precedent for 
providing a free and accessible repository for researchers to access and a 
reporting mechanism for effectiveness and safety. A substantial proportion 
of the real- world experience of hybrid closed-loop systems has come from 
the DIY APS community [8,9].  
 
Melmer and colleagues undertook a secondary analysis of 19495 days 
(53.4 years) of CGM data donated by 80 OpenAPS users [15]. They found 
individuals using DIY APS were achieving levels of glycemic control and 
variability that aligned with recently recommended clinic targets for CGM 
[16]. Petruzelkova, et al. conducted a pilot study comparing glycemic 
outcomes in 22 children (aged 6-15 years old) who were using either DIY 
APS (Android APS) or Smartguard systems during a 3-day winter ski camp 
[17]. They found that DIY APS to be ‘a safe and feasible alternative to the 
‘Smartguard Technology’ during and after sustained physical activity. A 
survey of 209 caregivers for children and adolescents with T1D using DIY 
APS across 21 countries reported a reduction in HbA1c by 0.64% and an 
increased TIR of 16.48% [18]. These findings mirror themes identified by 
Litchman, et al. who analysed Twitter data from 328 OpenAPS users who 
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reported improved HbA1c, glucose variability, and quality of life with a 
reduced sense of diabetes burden [19]. 
 
Using this dataset self-reported outcomes have been published that provide 
a wealth of data on effectiveness and safety in non-constrained trial 
settings. The reports all identify the following outcomes: 
 Increased time in range 
 Reduced glucose variability 
 Reduced episodes of hypoglycemia 
 Less reliance on accuracy of carbohydrate counting 
 Improved overnight control  
 Reduced mental burden  
 
One limitation of these studies is that DIY users are perceived to represent 
a self-selected group of motivated and highly engaged individuals which 
skew the interpretation and generalizability of these findings.  However, 
similar critiques have been levelled at other randomized control diabetes 
technology trials that mainly recruited engaged and well-informed 
participants [20]. Therefore, these studies reporting real-world outcomes  
provide relevant insights into the potential benefits and limitations of DIY 
APS in line with reports from commercial APS undergoing clinical trials [21].   
 
The following is an Accepted Manuscript which has been made available as an Open access 
version. The final copy-edited and typeset article is available from: 
Jennings, P., & Hussain, S. (2019). Do-It-Yourself Artificial Pancreas Systems: A Review of the 
Emerging Evidence and Insights for Healthcare Professionals. Journal of Diabetes Science and 
Technology. https://doi.org/10.1177/1932296819894296 
 
Copyright © 2019 Peter Jennings & Sufyan Hussain 
https://doi.org/10.1177/1932296819894296 
Page 10 of 29 
 
 
Why choose unregulated DIY APS systems?  
The use of complex technologies such as CSII and CGM can offer improved 
metabolic benefits and quality of life for those with T1D [22]. However, the 
training required, time taken for continuous self-management and decision 
making with these technologies can also cause a burden that forms a barrier 
to achieving favorable metabolic and psychological outcomes [22]. Artificial 
pancreas systems that can constantly adapt to changing physiology and 
activities for PWD offer great advantages. As highlighted earlier, the real-
world evidence base from DIY APS supports this expectation.  
 
A recent survey presented as a poster at ADA in 2019 [23] studied 
motivations to pursue unregulated DIY APS systems. This survey sampled 
over 1058 participants of which 19.8% were caregivers. Respondents’  
motivations for using DIY APS were to achieve better overall glycemic 
control, to reduce short and long-term complications, to alleviate the burden 
of diabetes and to improve sleep for PWD and their caregivers.  
 
Real-world use of the commercially available and medically regulated 670G 
system has highlighted some challenges.  These include alarm fatigue, 
accurate carbohydrate meal time entry, requirement for changing to manual 
mode in unexpected or extreme changes (e.g. hyperglycemia, sick days), 
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challenge with delayed meal absorptions (e.g. gastroparesis), and 
calibration requirements [24]. Such challenges may  limit the widespread 
utility of this commercially available system despite its potential benefits.  
 
Developers of DIY APS have designed systems that offer improved 
interoperability and customizable settings [25]. From our clinical experience 
these factors influence PWD’s decisions to use DIY APS over commercial 
APS especially for those who prefer to use particular sensor or pump 
devices, to view and program APS via smartphones and smartwatches,  to 
use remote monitoring possibilities. PWD using DIY APS also highlight 
challenges relating to time, effort and costs associated with building and 
learning to use the systems. Many seek support from the online 
communities [26].  
 
Other benefits include the ability to review and adjust the code, having 
different features and built in training steps for some DIY APS options and 
responsive community support. In our practice, the use of DIY APS in 
situations such as surgery, pregnancy, young infants, steroid treatment, 
intensive prolonged exercise, religious fasting and delayed or omissions in 
mealtime bolus has given a wealth of clinical experience on the high level 
of metabolic control DIY APS can offer in extreme physiology and complex 
clinical, some of which have been reported previously [27].  This contrasts 
The following is an Accepted Manuscript which has been made available as an Open access 
version. The final copy-edited and typeset article is available from: 
Jennings, P., & Hussain, S. (2019). Do-It-Yourself Artificial Pancreas Systems: A Review of the 
Emerging Evidence and Insights for Healthcare Professionals. Journal of Diabetes Science and 
Technology. https://doi.org/10.1177/1932296819894296 
 
Copyright © 2019 Peter Jennings & Sufyan Hussain 
https://doi.org/10.1177/1932296819894296 
Page 12 of 29 
 
to experiences from working with the current commercially available 
regulated system (670G). Others highlight that whilst the 670G system 
improves time in range, it is less able to cope with variations in illnesses, 
lifestyles, extreme physiology or other situations which require 
modifications of targets [24].  
Financial Drivers of DIY APS 
Another motivation is potential lower costs of using DIY APS as compared 
to commercial systems. In the majority of the developed world, access to 
CSII and real-time CGM systems is limited due to high acquisition and 
running costs. For individuals self-funding and using older CSII systems 
capable of connectivity, DIY APS offers an approach to avoid further 
acquisition costs. For individuals who are unable to afford real-time CGM, 
DIY APS can analyze glucose data collected from ‘DIY CGM’ systems using 
adaptations to flash glucose monitoring at reduced cost [8,28]. This is 
raising concerns relating to the manipulation of an existing device beyond 
its intended use with potential pitfalls of reduced accuracy. This could 
impact on reliable glucose data and safe automated insulin dosing. Given 
the observed rise in access to flash glucose monitoring in the UK and other 
healthcare systems, this important topic requires further research to inform 
future discussions.  
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Ethical and Regulatory Constraints  
DIY technologies are an example of a patient led care model, where 
technologies are developed by consumers bypassing testing and regulatory 
steps required for drugs and medically approved devices [29].  As discussed 
in this article, DIY APS may offer considerable advantages and benefits to 
the user over conventional methods of diabetes management and even 
commercially approved APS. Nevertheless, there are unresolved legal and 
ethical considerations for healthcare professionals who may wish to 
prescribe, support or even discuss these options with PWD or caregivers.  
Underlying this are unclear lines of accountability, in the event of an adverse 
event, between regulated device manufacturers, unregulated device 
manufacturers, algorithm coders, healthcare professionals, regulatory 
bodies such as FDA or MHRA and the end-user choosing to use an 
unregulated system.   
 
A few diabetes advocacy groups and centers have released statements to 
guide healthcare professionals, as well as the wider community, especially 
given some recent concerns [30–35]. Our interpretation of the consensus 
view for healthcare professionals from these, as well as personal 
communication with other professional groups and medical insurers in the 
UK are summarized below (Table 5). It is important to note that these are 
not professional guidelines. Current views from these statements are that 
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as DIY technologies are not regulated or medically approved, healthcare 
professionals should not prescribe, promote or initiate these options. 
However these statements do advise that healthcare professionals should 
support PWD to manage their condition in the way that they choose and 
should discuss unregulated DIY options if discussions are initiated by PWD 
to ensure open and transparent relationships.   
 
Reporting of issues relating to DIY APS largely relies on a very responsive 
T1D community, where such practices are encouraged for the benefit and 
safety of others. Issues and improvements to the code are also posted via 
GitHub [36]. Formal reporting structures may need to be modified to allow 
healthcare professionals or PWD a channel to disclose concerns whilst 
maintaining confidentiality and data protection for all involved, in a manner 
that can be reviewed and analyzed. Medwatch by the FDA and MHRA 
Yellow Card Scheme are examples of generic, formal reporting structures 
that have been suggested in the US and UK respectively [37,38]. They are 
designed for medications and regulated devices. Hence, although they 
provide a basic reporting mechanism with free text entry of information, they 
may not capture sufficient detail consistently to provide contextual 
information regarding DIY APS use to distinguish between user and system 
errors. This could lead to incorrect conclusions or inferences.  A recent case 
also highlights event reporting for patient led care models and its overall 
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perception by regulatory bodies [35,37]. The DIY APS community is a 
growing international community and a reporting mechanism that extends 
beyond individual countries would allow a more sophisticated way of 
capturing and collating data on safety.  
 
As discussed later, healthcare professionals have a strong role in 
supporting and educating PWD to make best use of diabetes technologies 
including DIY APS [39]. Whilst the above helps to provide a practice 
framework, it still does not resolve the ethical dilemmas or define lines of 
accountability or provide clarity over several situations routinely seen in 
clinics. For patient led care models, these aspects need further refinement. 
Until then, the healthcare professional groups will understandably remain 
cautious in their approach to DIY APS, despite the strong real-world data 
showing the benefits of using such systems. 
 
Roles of  HCP in DIY APS 
Current regulated and DIY APS systems both require PWD to have core 
skills in diabetes self-management. To make best use of the systems, key 
numeracy, carbohydrate counting and device management skills are 
needed. Meal announcement, bolus dose calculations and management of 
special situations such as exercise, sick days or technical failure may need 
manual interventions in these hybrid systems. The systems are reliant on 
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correct technical use of CSII and CGM systems. Hence, there is still a very 
strong role for HCP in understanding, implementing and supporting PWD 
via education, device selection and training to achieve optimal care via DIY 
APS [39,40].  
 
For HCP, there is an increasing role in facilitating and supporting 
technological systems of care where they are able to guide PWD on the 
best technological options for them. This requires an understanding and 
insight into the various technological systems and how they can be adapted 
depending on the clinical context and systems being used.  
 
The HCP may also play a key role in guiding PWD to use the automated 
technology. This requires support, training and behaviour change. Key 
aspects include managing expectations, building new habits around the 
technology and learning to trust the system. It also requires an 
understanding of the importance of patient support communities. For DIY 
APS, these are an integral part of support and learning for PWD, especially 
on technical and practical aspects that cannot be supported via HCP.  
 
The implementation of APS requires a model where there is emphasis on 
increased initial training and education at initiation. The AndroidAPS 
integrates step by step training in a graded manner requiring the user to 
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work through a sequence of objectives in order to unlock further automated 
dosing features. Our experience highlights that correct initiation and use 
can reduce the need for ongoing HCP and PWD or carer interaction. We 
have also noted that using automated systems allows HCP to spend less 
time on reviewing, analysing, changing treatment variables in clinic visits. It 
allows HCP to utilise their time with PWD more effectively and address other 
aspects of T1D care including psychological and emotional well-being.  
 
DIY APS Training for HCP  
Boughton and Hovorka highlight the need for diabetes specialist HCP to 
develop skills in using APS [41]. Traditionally, like the pharmaceutical 
industry, manufacturers of medical devices invest heavily in providing and 
sponsoring education for HCP to use their systems and promote research 
related to their devices to demonstrate effectiveness. This is done to 
develop skills, confidence and awareness to use new devices and systems. 
However, industry sponsored research and education may bias HCP 
understanding and interpretation of evidence.   
 
Nevertheless, this approach is utilized for commercial APS. However, DIY 
APS, being a patient-led initiative, does not receive the same level of 
industry sponsored support for education and research.  
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Healthcare professionals supporting PWD are becoming aware of DIY APS. 
However, many need to develop a deeper understanding of DIY APS and 
its potential benefits and limitations. Given the demand and interest, training 
opportunities for healthcare professionals to learn about DIY APS are 
becoming available [42].  People using DIY APS have created online 
learning resources for healthcare professionals that clearly summarize 
relevant information about how DIY APS works [10,11,40].  
 
Future Research Priorities for DIY APS 
While the evidence on DIY APS consistently shows users achieve 
decreased HbA1c values and increased TIR, important research questions 
remain unanswered. Potential topics include identifying characteristics and 
motivations of PWD exploring, building and using DIY APS; assessing 
impact upon quality of life and diabetes burden; and, understanding 
potential barriers that influence PWD to not use DIY APS [43].  
 
Future directions for DIY APS related research includes a European Commiss ion 
funded initiative, The OPEN Project, which provides a patient and user-led 
quantitative and qualitative research approach [44]. Given the lack of resources for 
formal trials, it is likely that such approaches will help provide further real-world 
evidence including quality of life data. Tidepool, a non-profit software 
organization, has recently secured funding from partners like the JDRF and 
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Helmsley Charitable trust to deliver an FDA regulated version of Loop, which is 
currently a DIY closed loop application [45]. Similarly, a group in New Zealand 
recently received funding and approval for an RCT using a version of AndroidAPS 
[46].  How a regulated application would impact use DIY APS in future is unclear.  
 
Conclusion  
DIY APS is radically changing T1D management. The automation of the 
process of frequently analyzing glucose readings and appropriately titrating 
insulin delivery is liberating PWD from some of the demands of intensively 
managing T1D. PWD require access to CSII and CGM, motivation and peer 
support to access, build and use DIY APS. The rapidly growing awareness 
and use of DIY APS is being facilitated via social media and support from 
DIY APS online communities.  
 
Within this super-specialized area of T1D management, the expertise of DIY 
APS users has outstripped that of many HCP. While educational, ethical 
and legal constraints need to be resolved, HCP still need to stay abreast of 
this rapidly developing area.  Further research is needed to inform policy 
and practice relating to DIY APS. Meanwhile, HCP continue to learn from 
PWD’s real-world experiences of building and using DIY APS to improve 
metabolic and psychological outcomes.  
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Tables 
Table 1. DIY APS Quantitative Research Literature 
 
Authors Country Research Methods  Aims Sample (n=) Outcomes 







Secondary Analysis of donated data sets 
on OpenAPS Repository 
Describe DIY APS Outcomes:  





19495 days (53.4 years) of CGM records analyzed 
MGa = 7.6 ± 1.1 mmol/L 
eA1cb= 6.4 ± 0.7% 
TIR
c
=77.5 ± 10.5%  
TBRd=4.3 ± 3.6% 
TAR
e
=18.2 ± 11.0% 






3-day pediatric winter ski camp 
Compare DIY APS vs 
SmartGuard outcomes: mean 
glucose & TIR: Predictive low 
glucose suspend (PLGS) vs Android 
APS (AAPS) 
22 children 
(6–15 years old)  
 PLGS AAPS P value 
MG 7.7 – 2.8 7.2 – 2.7 <0.042 
TIR 82% (64 to 85) 82% (77 to 86) 0.3 
TBR  3% (2 to 4.5) 5% (2 to 6) 0.6 
TAR 23.6 ± 14.7% 15.4 ± 9.3% < 0.0001 
 




Assess DIY APS Outcomes: 
HbA1c, TIR before and after 
DIYAPS initiation and problems 
during DIYAPS use 
209 caregivers 
from 21 countries 
 












Hng & Burren, 2018[47] Australia  Quantitative 
Online Survey 
DIY APS Users’ Characteristics 
& Outcomes 
19 DIY APS Users 
(‘Loopers’) 
‘Loopers’ reported   
(i) more time in target glucose range (100%) 
(ii) better sleep (79%) 
(iii) less frequent hypoglycaemia (74%) 
(iv) improved HbA1c (68%) 
(v) less severe hypoglycaemia (53%) 
(vi) more confidence (47%) 
(vii) more energy (37%) 
(viii) fewer mood swings (32%) 
 
Lee, et al. 2017[48] USA Quantitative 
Online Survey 
Evaluate changes in health 
behaviors and health outcomes 
associated with Nightscout use 
 
Compare demographic and 
disease charac- teristics of 
users versus nonusers of 
Nightscout 
 
Describe the uses and 
personalization of Nightscout 
1268 members of 




Nightscout users reported significant improvements in HbA1c and QoL 
   
Nightscout Users’ Characteristics: 
 Non-Hispanic whites (90.2%) 
 type 1 diabetes (99.4%) 
 Using Insulin Pump Therapy (85.6%) and CGM (97.0%) with  
 Private health insurance (83.8%). 
 
 Nightscout use was more prevalent among children compared with 
adolescents and adults 
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a MG=Mean Glucose  beA1c=estimated HbA1c  cTIR= Time in Range (3.9–10mmol/L)  dTime Below Range (< 3.9mmol/L) eTime Above Range (>10mmol/l) 
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Table 2. DIY APS Qualitative Research Literature 
 
Authors Country Research Methods  Aims Sample (n=) Outcomes 








Tw itter over a tw o-
year period 
Examine Tw itter data to 
understand how  patients, 
caregivers, and care partners 
perceive OpenAPS, the personal 
and emotional ramifications of 
using OpenAPS, and the influence 
of OpenAPS on daily life 
328 participants’    
3347 tw eets 
Overarching theme:  OpenAPS changes lives 
5 subthemes relating to OpenAPS use emerged from the data:  
(1) Improved self -reported A1C and glucose variability  
(2) Improved sense of diabetes burden and quality of life 
(3) OpenAPS perceived as safe 
(4) Patient/Caregiver-Provider interaction related to OpenAPS 
(5) Technology adapted for OpenAPS users’ needs  







Describe Nightscout Outcomes:  
Glycaemic control & variability 
 
20 interview s ‘Members of the CGM in the Cloud Facebook group identif ied 
peer support through giving and receiving technical, emotional, 
and medical support, as w ell as giving back to the larger 
community by paying it forward. Peer support also extended 
beyond the online forum, connecting people in person, w hether 
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Table 3. DIY APS Selection of Unpublished Research 
 
Authors Country Format Research Methods Aims Sample (n=) Outcomes  



















Adult users (80.2%; 43% female; median age 41 years) with T1D 
(98.9%) for 25.2 years ±13.3 
 
Caregivers for children (19.8%; 47.4% female; median age 10 years) 
with T1D (99.4%) for 5.1 years ±3.9. 
(Post Treatment = Post-Tx) 
 HbA1c Baseline HbA1c Post- Tx 
OpenAPS 7.07% ±1.07 
 
6.24% ±0.68 % 
 
TIR   63.21% ±16.27 
 
 83.07% ±10.11 
 
 
Cost ($USD/year)  $712 
 
Wilmot et al., 
2019[49] 
UK Poster Case Review  Comparing 
glucose 
outcomes 




9 Open APS 
users 
 




 Baseline Post-Tx P value 
OpenAPS 
HbA1c 


































continuous BG (blood 
glucose) readings 
recorded during 2-
w eek segments 4-6 
w eeks before and after 
initiation of OpenAPS 
 
To compare 









 Pre-Open APS Post-Open APS 
HbA1c 6.4% 6.1% 
Mean BG 135.7 mg/dl 
 
128.3 mg/dl 



















= 19/11; age = 
35.9 years ± 
12.52 DS) w ith 
T1D  
 
 Baseline Post-Tx P value 
HbA1c  7.17% ± 0.49 
 
6.61% ± 0.47 <0.05 
%Time 
Hypo 
 8.55% ± 5.81 o  
 





The following is an Accepted Manuscript which has been made available as an Open access version. The final copy-edited and typeset article is available from: 
Jennings, P., & Hussain, S. (2019). Do-It-Yourself Artificial Pancreas Systems: A Review of the Emerging Evidence and Insights for Healthcare Professionals. 
Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296819894296 
 
Copyright © 2019 Peter Jennings & Sufyan Hussain 
https://doi.org/10.1177/1932296819894296 














Poster Case Review  To compare 
HbA1c, TIR 
(80-180 mg/dl) 
time in high 






11.9 ± 6.9 
years; Median 
openAPS 




 Baseline Post-Tx P value 
HbA1c  6.8 ± 1.0%  
 
6.3 ± 0.7% <0.001 


















Users (67% male, 61% adults, median age 27 years, 15 years with 
T1D, 10 years on pump, 3 years on CGM 
 
 HbA1c Baseline HbA1c Post-Tx 
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Table 4. DIY APS Other Publications 
 
Authors Country Literature Type Focus 
Marshall et al, 2019 
[54] 
UK Commentary Patient physician perspective of 3 cases highlighting benefits of using DIY APS 
and utilising this approach in pregnancy, care of a child and surgery 
Patton, 2019[55] Australia Case Report User’s Experience from One year of DIY APS 
Crabtree et al., 
2019[8] 
UK Review  DIY APS: Principles, Outcomes, Ethics 
de Bock, 2019[29] Australia Editorial 
 
DIY APS Dilemmas facing Healthcare Professionals 
Waugh et al., 2018[7] UK Editorial 
 
Need for DIY APS Research 
Barnard et al., 
2018[56] 
International Commentary DIY APS Overview  & Dilemmas 
Lew is, 2018[13] 
 
USA View point 
 
DIY History, Pro's and Con's, Impact 
Lee et al., 2016[57] USA View point 
 
Nightscout Overview  and Regulatory Dilemmas 
Lew is et al., 2018[39] USA Letter to Editor Setting Expectations for Successful Artificial Pancreas/Hybrid Closed 
Loop/Automated Insulin Delivery Adoption 
Lew is et al., 2016[53] USA Letter to Editor Real-World Use of Open Source Artif icial Pancreas Systems 
Lew is, 2019[40] USA Monograph DIY APS User's Guide 
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Table 5. Consensus from various statements produced on DIY APS use for healthcare professionals  
 
Issues Guidance for Healthcare Professionals Authors 
Prescribing Not regulated and not medically approved Diabetes Australia [30], JDRF UK [31],  
Steno Diabetes Center Copenhagen 
[32],  Diabetes UK [33], FDA [34]  
Cannot prescribe, promote, initiate or recommend Diabetes Australia [30], JDRF UK [31],  
Steno Diabetes Center Copenhagen 
[32],  Diabetes UK [33]  
Must only recommend authorised technology  Diabetes Australia [30], JDRF UK [31],  
Steno Diabetes Center Copenhagen 
[32],  Diabetes UK [33] 
Discussing Should discuss if topic is raised by person with diabetes or 
carer, especially risks and medically unregulated status  
Diabetes UK [33] 
Supporting  Respect the right of individuals to choose how they wish to 
manage their or their dependant’s diabetes 
Diabetes Australia [30], JDRF UK [31],  
Steno Diabetes Center Copenhagen 
[32],  Diabetes UK [33] 
Continue to support and provide regulated devices (pump, 
CGM, Flash GM) if meet criteria even if patient intends to 
pursue DIY APS 
Diabetes Australia [30], JDRF UK [31],  
Steno Diabetes Center Copenhagen 
[32],  Diabetes UK [33] 
Cannot help with procurement of medical equipment other 
than approved systems  
Steno Diabetes Center Copenhagen 
[32] 
Can help with evaluation of glucose values and insulin dosing 
via information from DIY APS platforms but may not provide 
advice on DIY APS settings 
Steno Diabetes Center Copenhagen 
[32] 
Cannot refer to unregulated information sources Steno Diabetes Center Copenhagen 
[32] 
Should direct PWD to online DIY APS communities for advice Diabetes UK [33] 
Documenting Ensure clear documentation of discussions with patients or 
carers, especially discussions regarding risks and 
unregulated status of DIY APS 
Diabetes UK [33] 
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